Peroxisomes IPA: [pɛɜˈɹɒksɪˌsoʊmz] (also called microbo... -

Peroxisomes IPA: [pɛɜˈɹɒksɪˌsoʊmz] (also called microbo...

wikipedia - 12 Sep 2016
Peroxisomes IPA: [pɛɜˈɹɒksɪˌsoʊmz] (also called microbodies) are organelles found in virtually all eukaryotic cells. They are involved in catabolism of very long chain fatty acids, branched chain fatty acids, D-amino acids, and polyamines, reduction of reactive oxygen species – specifically hydrogen peroxide – and biosynthesis of plasmalogens, i.e. ether phospholipids critical for the normal function of mammalian brains and lungs. They also contain approximately 10% of the total activity

Atlanta family hopes all Pound the Pavement for Peter - 08 Mar 2018
This year's event will benefit three nonprofits: the Global Foundation for Peroxisomal Disorders, which funds and promotes peroxisome disorder research and helps families and professionals through educa-tional programs and support; the Adaptive ...

Newsmaker: Tulsa-based Peroxisomal foundation names director, board

Tulsa World - 16 Feb 2018
The nonprofit funds and promotes peroxisome disorder research as well as provides support to patients with peroxisomal disorders and their families. “Our board of directors has always been a dynamic, hard-working group,” Gamble said. “We're grateful ...

Study identifies gene that influences risk of obesity in adulthood - 13 Mar 2018
A team of researchers led by Tokyo Medical and Dental University (TMDU) previously found that upon the onset of lactation after birth, milk lipids serve as a ligand to activate the nuclear receptor peroxisome proliferator-activated receptor (PPAR)α ...

Analyzing Aralez Pharmaceuticals (ARLZ) & XenoPort (XNPT ...

Macon Daily - 18 Mar 2018
XenoPort (NASDAQ: XNPT) and Aralez Pharmaceuticals (NASDAQ:ARLZ) are both healthcare companies, but which is the better stock? We will compare the two businesses based on the strength of their institutional ownership, analyst recommendations ...

Metaphoric microcephaly caused by MCQ exams

Times of India (blog) - 04 Mar 2018
As the pathogenic strain driving this national malaise causing global losses to human race is MCQ, we need to understand its pathology in human brain. If I look at questions from NEET, an examination that decides who should be saving your life if you ...

Analysts See $-0.22 EPS for Cymabay Therapeutics, Inc. (CBAY)

Frisco Fastball - 14 Mar 2018
Cymabay Therapeutics, Inc., a biopharmaceutical company, focuses on developing and commercializing therapies to treat specialty and orphan diseases. The company has market cap of $767.94 million. It engages in developing seladelpar , a selective ...

$-0.17 EPS Expected for Cymabay Therapeutics, Inc. (CBAY)

Frisco Fastball - 13 Mar 2018
H.C. Wainwright maintained Cymabay Therapeutics, Inc. (NASDAQ:CBAY) rating on Wednesday, March 30. H.C. Wainwright has “Buy” rating and $6 target. Cymabay Therapeutics, Inc., a biopharmaceutical company, focuses on developing and commercializing ...

What's New